Key Findings (20-year risks in early-onset AF vs matched controls): Stroke: 6.9% | 2x higher risk Heart Failure: 6.5% | 45x higher risk Death: 7.1% | 1.4x higher risk Take-home message: Even in the absence of traditional comorbidities, early-onset AF is a marker of future cardiovascular complicationsespecially cardiomyopathy and HF
Yet clinicians increasingly ask whether these effects persist or evolve after several years of therapy
Barboi OB, Chirila I, Ciortescu I, Anton C, Drug VL
Selenium strongly influences the activity of T-lymphocytes , the immune systems natural killer cells, which defend the body and can even destroy tumor cells
NutraKey creates clean, science-driven supplements that fuel performance, recovery, and overall health
[Crossref] [Google Scholar] [PubMed] Cui J, Wang J, Lv Y, Xu D